The Scientist

» industry and developmental biology

Most Recent

image: Contributors

Contributors

By | August 1, 2015

Meet some of the people featured in the August 2015 issue of The Scientist.

0 Comments

image: Drugging the Environment

Drugging the Environment

By | August 1, 2015

Humans have spiked ecosystems with a flood of active pharmaceuticals. The drugs are feminizing male fish, confusing birds, and worrying scientists.

7 Comments

image: Leaving an Imprint

Leaving an Imprint

By | August 1, 2015

Among the first to discover epigenetic reprogramming during mammalian development, Wolf Reik has been studying the dynamics of the epigenome for 30 years.

1 Comment

image: Mimicry Muses

Mimicry Muses

By | August 1, 2015

The animal world is full of clever solutions to bioengineering challenges.

0 Comments

image: Mr. Epigenetics

Mr. Epigenetics

By | August 1, 2015

Meet Wolf Reik, August Profilee and Babraham Institute director of research.

0 Comments

image: Rethinking Lymphatic Development

Rethinking Lymphatic Development

By | August 1, 2015

Four studies identify alternative origins for cells of the developing lymphatic system, challenging the long-standing view that they all come from veins.

1 Comment

image: The Prescient Placenta

The Prescient Placenta

By | August 1, 2015

The maternal-fetal interface plays important roles in the health of both mother and baby, even after birth.

1 Comment

image: HHS Partners on Ebola Drug

HHS Partners on Ebola Drug

By | July 22, 2015

The US Department of Health and Human Services will put nearly $20 million toward the development of an Ebola drug as Tekmira steps out of the space.

0 Comments

image: More Transparency in IRB-Industry Ties

More Transparency in IRB-Industry Ties

By | July 13, 2015

Conflicts of interest among institutional review board members are disclosed more often than they were a decade ago, according to a survey of academics.

0 Comments

image: CAR-T Therapies Get $1 Billion Boost

CAR-T Therapies Get $1 Billion Boost

By | July 1, 2015

The biotech firm Celgene inks a huge collaboration deal with Juno Therapeutics to develop and commercialize new cancer immunotherapies.

0 Comments

Popular Now

  1. Antarctica Is Turning Green
  2. How to Tell a Person’s “Brain Age”
  3. Male Fish Borrows Egg to Clone Itself
  4. Life Science Funding Cuts Leaked
    The Nutshell Life Science Funding Cuts Leaked

    According to a document posted online less than a day before the release of the official 2018 budget proposal, the National Institutes of Health could face even deeper cuts than previously suggested by the Trump administration.

AAAS